This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Multi Detector-Row Computed Tomography (MDCT) Calcium Score of Heart Transplanted Patients

This study has been completed.
Information provided by:
Oslo University Hospital Identifier:
First received: February 21, 2006
Last updated: July 3, 2011
Last verified: April 2008
The purpose of the study is to determine if calcium score can be used as a predictor of coronary artery disease in heart transplanted patients, as it is used in non-transplanted persons.

Condition Intervention
Coronary Artery Disease Procedure: MDCT calcium score

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: MDCT Calcium Score of Heart Transplanted Patients

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Calcium score [ Time Frame: at the date of examination ]

Secondary Outcome Measures:
  • Coronary stenoses found on coronary angiography [ Time Frame: at the date of examination ]

Estimated Enrollment: 240
Study Start Date: December 2005
Estimated Study Completion Date: June 2007
Detailed Description:
Several studies have shown that a negative calcium score is a strong independent negative predictor of coronary artery disease (CAD). CAD in heart transplants (HTx) differs from CAD lesions in native hearts. The aim of this study is to see if there is a similar relation between coronary artery calcium and CAD in transplanted hearts as in native hearts.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Heart transplanted patient
  • Aged 18 or above.

Exclusion Criteria:

  • Pregnancy
  • Atrial fibrillation
  • Severe heart failure New York Heart Association (NYHA) class IV
  • Severe pulmonary disease making the patient unable to hold his/her breath for more than 10 seconds.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00294853

Rikshospitalet-Radiumhospitalet HF
Oslo, Norway, 0020
Sponsors and Collaborators
Oslo University Hospital
Principal Investigator: Anne Günther, MD Oslo University Hospital
  More Information Identifier: NCT00294853     History of Changes
Other Study ID Numbers: S-05099
Study First Received: February 21, 2006
Last Updated: July 3, 2011

Keywords provided by Oslo University Hospital:
Coronary calcium score
Coronary artery disease
Cardiac transplantation
Coronary calcium score in heart transplanted patients
Coronary artery disease in heart transplanted patients

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases
Calcium, Dietary
Bone Density Conservation Agents
Physiological Effects of Drugs processed this record on September 21, 2017